Acute Pain Clinical Trials

Find Acute Pain Clinical Trials Near You

Using Sensorimotor Reorganization Following Upper Limb Amputation to Improve Prosthetic Control

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Amputation of an upper limb results in a disruption of the sensorimotor loop and a reorganization of the nervous system, leading to the emergence of a phantom limb and the adaptation of compensatory motor strategies. This project aims to leverage these phenomena (induced sensations, phantom mobility, and compensations) to improve control, sensory feedback, and the appropriation of prostheses, in order to reduce cognitive load and musculoskeletal disorders.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• people aged 18 or more

• amputation or agenesis of one uper limb, above the wrist or higher

• understanding of the French language and the ability to express onself in that language (for semi-structured interviews)

• affiliation to a social security programm

Locations
Other Locations
France
Institut Régional de Médecine Physique et de Réadaptation, Filière Locomoteur
RECRUITING
Nancy
Fondation Saint-Hélier
RECRUITING
Rennes
Contact Information
Primary
Amélie Touillet
amelie.touillet@ugecam.assurance-maladie.fr
+333 83 52 97 00
Backup
Jonathan Pierret, PhD
jonathan.pierret@ugecam.assurance-maladie.fr
+333 83 52 97 00
Time Frame
Start Date: 2026-04-15
Estimated Completion Date: 2030-04-30
Participants
Target number of participants: 50
Treatments
Experimental: Phantom-limb and motor compensation evaluation
Related Therapeutic Areas
Sponsors
Leads: Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
Collaborators: Institut des Sciences du Mouvement, Laboratoire des Sciences du Numérique de Nantes, Institut des Systèmes Intelligents et de Robotique, Institut de Recherche en Informatique et Systèmes Aléatoires

This content was sourced from clinicaltrials.gov